Discovery of a new series of centrally active tricyclic isoxazoles combining serotonin (5-HT) reuptake inhibition with alpha2-adrenoceptor blocking activity.

Source:http://linkedlifedata.com/resource/pubmed/id/15771448

J. Med. Chem. 2005 Mar 24 48 6 2054-71

Download in:

View as

General Info

PMID
15771448